When scientists turned on the 'stop eating' signal in mice’s brains and then gave a drug to block nicotine-like signals, the mice still ate less — meaning something else besides nicotine-like signals is also helping to suppress hunger.
Scientific Claim
In mice, the appetite-suppressing effect of activating cholinergic neurons in the diagonal band of Broca is only partially reversed by blocking nicotinic receptors, suggesting muscarinic receptors or other neurotransmitters may also contribute to appetite regulation.
Original Statement
“In the presence of mecamylamine, photostimulated animals showed a blunted response compared to stimulation alone... suggesting that decreased food intake after stimulation was mediated in part by AChR signalling... may therefore explain why nAChR antagonism alone was not sufficient to fully suppress feeding.”
Evidence Quality Assessment
Claim Status
overstated
Study Design Support
Design cannot support claim
Appropriate Language Strength
association
Can only show association/correlation
Assessment Explanation
The partial reversal suggests additional mechanisms, but the study does not isolate or test muscarinic or GABAergic contributions directly. The claim implies a mechanistic conclusion beyond the evidence.
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Randomized Controlled TrialLevel 1bWhether selective blockade of muscarinic receptors, alone or combined with nicotinic blockade, fully reverses cholinergic-mediated appetite suppression in mice.
Whether selective blockade of muscarinic receptors, alone or combined with nicotinic blockade, fully reverses cholinergic-mediated appetite suppression in mice.
What This Would Prove
Whether selective blockade of muscarinic receptors, alone or combined with nicotinic blockade, fully reverses cholinergic-mediated appetite suppression in mice.
Ideal Study Design
A double-blind, randomized trial in 60 Chat-cre;ChR2 mice, randomized to receive saline, mecamylamine (nAChR blocker), atropine (mAChR blocker), or both, followed by optogenetic stimulation of DBB neurons, with food intake measured over 2 hours.
Limitation: Still limited to mice; cannot determine if this applies to humans.
Case-Control StudyLevel 3bWhether mice with selective deletion of muscarinic receptors in POMC neurons show altered responses to DBB cholinergic stimulation.
Whether mice with selective deletion of muscarinic receptors in POMC neurons show altered responses to DBB cholinergic stimulation.
What This Would Prove
Whether mice with selective deletion of muscarinic receptors in POMC neurons show altered responses to DBB cholinergic stimulation.
Ideal Study Design
A case-control study comparing 20 Pomc-Cre;M3R-floxed mice with 20 controls, measuring food intake and POMC neuron firing in response to DBB optogenetic stimulation under blinded conditions.
Limitation: Does not test if muscarinic receptors are necessary in other cell types or brain regions.
In Vitro StudyLevel 5Whether acetylcholine activates POMC neurons via muscarinic receptors in isolated hypothalamic slices.
Whether acetylcholine activates POMC neurons via muscarinic receptors in isolated hypothalamic slices.
What This Would Prove
Whether acetylcholine activates POMC neurons via muscarinic receptors in isolated hypothalamic slices.
Ideal Study Design
An in vitro study using patch-clamp recordings from POMC-EGFP neurons in hypothalamic slices, applying acetylcholine with and without selective mAChR antagonists (e.g., darifenacin) and nAChR blockers, with repeated trials per neuron.
Limitation: Lacks behavioral context and circuit-level integration.
Animal Study (Cross-Sectional)Level 4Whether cholinergic DBB neurons co-express GABA and whether this correlates with feeding behavior.
Whether cholinergic DBB neurons co-express GABA and whether this correlates with feeding behavior.
What This Would Prove
Whether cholinergic DBB neurons co-express GABA and whether this correlates with feeding behavior.
Ideal Study Design
A cross-sectional study using dual-label immunofluorescence for ChAT and VGAT in 30 mice, quantifying co-expression in DBB neurons and correlating with baseline food intake and body weight.
Limitation: Shows co-expression, not functional contribution to appetite suppression.
Prospective Cohort StudyLevel 2bWhether the degree of residual appetite suppression after nicotinic blockade varies across individual mice and correlates with muscarinic receptor expression.
Whether the degree of residual appetite suppression after nicotinic blockade varies across individual mice and correlates with muscarinic receptor expression.
What This Would Prove
Whether the degree of residual appetite suppression after nicotinic blockade varies across individual mice and correlates with muscarinic receptor expression.
Ideal Study Design
A prospective cohort of 50 mice, measuring residual food intake suppression after mecamylamine during DBB stimulation, and correlating with mRNA levels of M1–M5 receptors in the arcuate nucleus.
Limitation: Cannot prove causation — only association.
Evidence from Studies
No evidence studies found yet.